NCT06054100View on ClinicalTrials.gov

The Effect of Colchicine on Inflammation in ACS Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

88

Participants

Timeline

Start Date

February 1, 2020

Primary Completion Date

February 15, 2022

Study Completion Date

May 20, 2022

Conditions
Acute Coronary SyndromeSTEMI
Interventions
DRUG

Colchicine Tablets

Colchicine oral tablets loading dose of 1mg every 12 hrs for 1 day, followed by 0.5 mg BID for 3 months

Trial Locations (1)

Unknown

Ain shams university, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT06054100 - The Effect of Colchicine on Inflammation in ACS Patients | Biotech Hunter | Biotech Hunter